Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2002
08/15/2002US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators
08/15/2002US20020110839 Micro-array evanescent wave fluorescence detection device
08/15/2002US20020110838 Diagnosing muscle protein wasting in humans; obtain muscle tissue, separate solubilized proteins, incubate with ligand, detect ligand binding, compare to control
08/15/2002US20020110837 Detecting modulators of nervous system activity; obtain cells, incubate with modulators, monitor adjustment in nervous system activity
08/15/2002US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor
08/15/2002US20020110833 Methods to diagnose a required regulation of trophoblast invasion
08/15/2002US20020110831 Method and apparatus for controlling an electric current through bio-molecules
08/15/2002US20020110830 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity
08/15/2002US20020110826 Oligonucleotide probe for use in hybridization analysis
08/15/2002US20020110825 Apparatus for use in applying magnetic fields to microtiter plate
08/15/2002US20020110823 Screening human to determine proability of side effects to surgery; obtain tissue sample, extract nucleotide sequences, determine expression pattern of preferential genes
08/15/2002US20020110818 Methods of analyzing polymers using ordered label strategies
08/15/2002US20020110817 Device for containing, reacting and measuring, and method of containing, reacting and measuring
08/15/2002US20020110816 Method for screening microcrystallizations for crystal formation
08/15/2002US20020110814 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
08/15/2002US20020110806 Detecting preferential biopolymer on solid support; generate solid support joined with bioploymer, incubate with bacteriophage, remove unbound phage, detecting replicated bound bacteriophage
08/15/2002US20020110803 Highly cost-effective analytical device for performing immunoassays with ultra high sensitivity
08/15/2002US20020110801 Detecting modulator of brain activity; obtain neuronal cells, incubate with modulator, monitor activity of cells compare to control
08/15/2002US20020110800 Use of SHP-1 and SHP-2 to detect compounds involved in neuronal survival
08/15/2002US20020110799 Kidney disease detection and treatment
08/15/2002US20020110691 Label bound via an amide bond and a linker to a residue of the molecule characterized in that the N atom of the amide bond and the label are linked together directly by a covalent bond; phosphoramidites or reactive supports
08/15/2002US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH)
08/15/2002US20020110556 Introducing labeled antibodies or labeled alpha-fetaprotein (AFP) to biological sample so they will react with AFP receptor or AFP receptor binding sites in biological sample; identifying AFP receptor or its binding sites in sample
08/15/2002US20020110553 Use of antibiotic peptides produced by human corneal epithelial cells to manage infection
08/15/2002US20020110539 Modulated release particles for lung delivery
08/15/2002US20020110523 Determining whether an increase of compound on level of acute phase reactant or metabolic derivative has occurred since applying compound or to subject; increase in level of acute phase reactant indicates negative side effect
08/15/2002US20020110496 Sample tab
08/15/2002US20020110490 Organic and inorganic compounds with highly electronegative elements are selectively ionized by atmospheric pressure, ions produced are detected by mass spectrometer, and their amount is measured
08/15/2002US20020110487 Apparatus and method for handling fluids
08/15/2002US20020110486 Analyte test strip with two controls
08/15/2002US20020110267 Image metrics in the statistical analysis of DNA microarray data
08/15/2002US20020109087 Method for producing a catalyst support and compositions thereof
08/15/2002US20020109086 Method for growing continuous carbon fiber and compositions thereof
08/15/2002US20020108910 Determination of multi-valent metal contamination and system for removal of multi-valent metal contaminants from water
08/15/2002US20020108908 A polymeric support, a dye attached to a fraction of the polymeric support to enable optical detection of polymeric support, and an affinity ligand other than dye attached to a fraction of polymeric support for capture of biomolecule
08/15/2002US20020108870 Sensor has an electrochemical cell for reducing nitrogen oxides, thus producing oxygen ions that create a measurable current that is directly proportional to the nitrogen oxide concentration in a exhaust gas
08/15/2002US20020108857 Robotic-equipped modular stations; for amplification of genetic material for example; high-throughput and fully automated processing of genetic materials
08/15/2002US20020108430 Method and apparatus for the measurement of the interchangeability of LPG/air mixtures with natural gas
08/15/2002CA2796391A1 Myeloperoxidase, a risk indicator for cardiovascular disease
08/15/2002CA2440978A1 Myeloperoxidase, a risk indicator for cardiovascular disease
08/15/2002CA2438221A1 Steroidal derivatives
08/15/2002CA2438018A1 Markers of unstable atherosclerotic plaques
08/15/2002CA2437750A1 Prc17: an amplified cancer gene
08/15/2002CA2437727A1 Methods and compositions for modulating gluconeogenesis using pgc-1
08/15/2002CA2437717A1 G-protein coupled receptors
08/15/2002CA2437665A1 Gap junction permeability assay
08/15/2002CA2437648A1 Multipotent o-2a progenitors from the neurohypophysis
08/15/2002CA2437577A1 Human sphingosine-1-phosphate phosphatase
08/15/2002CA2437573A1 Methods for diagnosing and treating heart disease
08/15/2002CA2437571A1 Receptors and membrane-associated proteins
08/15/2002CA2437564A1 Compositions and methods for the therapy and diagnosis of breast cancer
08/15/2002CA2437498A1 Methods and kits for identifying scavengers of reactive oxygen species (ros)
08/15/2002CA2437497A1 Lipid-associated molecules
08/15/2002CA2437484A1 Ragweed allergens
08/15/2002CA2437480A1 Method of treating amyloid .beta. precursor disorder
08/15/2002CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
08/15/2002CA2437383A1 Alteration of phenotype due to heterologous genes
08/15/2002CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof
08/15/2002CA2437210A1 Apparatus and method of extracting volatile components
08/15/2002CA2437185A1 Timm8b-related protein
08/15/2002CA2436986A1 Ter sites and ter binding proteins
08/15/2002CA2436746A1 Charge tags and the separation of nucleic acid molecules
08/15/2002CA2436470A1 Intracellular signaling molecules
08/15/2002CA2436465A1 Prediction of wound healing by urinary nitrate assay
08/15/2002CA2436448A1 Rare event detection system
08/15/2002CA2435810A1 Cell fusion assays for the identification of antiviral compounds, and systems and kits for practicing the same
08/15/2002CA2435608A1 Low affinity screening method
08/15/2002CA2435255A1 Use of high density microparticles for removal of pathogens
08/15/2002CA2434944A1 Secreted proteins
08/15/2002CA2434881A1 Method for identifying functional nucleic acids
08/15/2002CA2433439A1 Proteins and nucleic acids encoding same
08/15/2002CA2432167A1 Methods for measuring stress in mammals
08/14/2002EP1231470A1 Method for immobilizing substances
08/14/2002EP1231469A1 Method of the diagnosis of renal disorder, hemolytic-uremic syndrome and intestinal hemorrhagic escherichia coli infection
08/14/2002EP1231468A1 Method for detecting exogenous endocrine disrupting chemical and detection apparatus
08/14/2002EP1231467A2 Methods for the analysis of mouth odor
08/14/2002EP1231278A1 Cell-free method for preparing post-translational modified proteins
08/14/2002EP1231276A1 Method for purifying proteins and/or biomolecule of protein complexes
08/14/2002EP1231271A2 DNA fragments of the GAG gene of Lav.
08/14/2002EP1231269A1 Methods and compositions for polypeptide engineering
08/14/2002EP1231263A1 Multipotent O-2A progenitors from the neurohypophysis
08/14/2002EP1231214A2 Biopolymer detector
08/14/2002EP1230895A1 Body fluid measuring instrument and body fluid sampler thereof
08/14/2002EP1230669A2 Infra-red light source
08/14/2002EP1230615A2 Method for manipulating protein or dna sequence data in order to generate complementary peptide ligands
08/14/2002EP1230552A2 Elisa for vegf
08/14/2002EP1230551A2 Methods to identify compounds that modulate neuronal activity
08/14/2002EP1230550A1 Flow matrix assay device with movable separating member
08/14/2002EP1230549A2 Method for solubilising optical markers
08/14/2002EP1230548A1 Methods for the quantitation of oxidized glutathione
08/14/2002EP1230547A2 Method for detecting heavy metals and/or organic noxious substances using plant cell suspensions
08/14/2002EP1230546A1 Method for assessing genotoxicity of a compound
08/14/2002EP1230545A1 Diagnostic testing kit for collection and testing of fluid samples with user configurable test strips and timer
08/14/2002EP1230540A1 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same
08/14/2002EP1230539A1 Microscopic multi-site sensor array with integrated control and analysis circuitry
08/14/2002EP1230509A1 Method and device for monitoring the flow of oil pertaining to a device for the oil and air lubrication of components
08/14/2002EP1230398A1 Colour labelled oligonucleotide for labelling a nucleic acid molecule
08/14/2002EP1230397A2 Molecular microarrays and methods for production and use thereof
08/14/2002EP1230396A2 Immunological detection of rna:dna hybrids on microarrays
08/14/2002EP1230395A2 Long oligonucleotide arrays